Intimate Partner Violence in the Late COVID-19 Period: A Study of 10 Countries from the I-SHARE Consortium
Intimate partner violence (IPV) is a serious public health issue and violation of human rights. During 2021–2022, many countries relaxed COVID-19 restrictions. This provided a unique opportunity to understand the prevalence and correlates of IPV during a period of relaxing COVID-19 restrictions. This cross-sectional study examined IPV during this period from the International Sexual HeAlth and REproductive Health (I-SHARE) study conducted from March to July 2022. Mixed-effects modeling was used to determine correlations of physical, sexual, and psychological violence as compared to before the COVID-19 restrictions. The population comprised individuals in 10 countries (Armenia, Brazil, Egypt, Denmark, Germany, Moldova, Nigeria, Portugal, Singapore and Spain). Our sample included 4,464 participants from these countries. In the previous 3 months, a total of 150 (6.1%) and 114 (4.6%) participants experienced physical violence once or multiple times, respectively. A total of 129 (5.1%) and 174 (6.9%) of participants experienced any form of sexual violence once or multiple times, respectively; and 377 (13.7%) and 574 (20.9%) of participants experienced any form of psychological violence once or multiple times, respectively. In general, identifying as a sexual minority and having children at home were associated with higher odds of experiencing IPV. Age, economic situation, cohabitation status, and a country’s GDP per capita were associated with recent IPV or a worsening of IPV compared to before the COVID-19 restrictions, although results varied depending on the types of violence. Further work is needed to strengthen IPV support for several groups, especially in emergency situations or future pandemics.
Authors
- Emmanuel Adebayo (ORCID: https://orcid.org/0000-0002-9148-4236)
- Adesola Olumide (ORCID: https://orcid.org/0000-0003-4372-9822)
- Rayner Kay Jin Tan (ORCID: https://orcid.org/0000-0002-9188-3368)
- Raquel Gómez Bravo (ORCID: https://orcid.org/0000-0002-3786-8626)
- Sonam Shah (ORCID: https://orcid.org/0009-0005-3608-5207)
- Ana Luísa Patrão (ORCID: https://orcid.org/0000-0002-2027-5461)
- Pedro Nobre (ORCID: https://orcid.org/0000-0003-2571-6972)
- Ana Paula dos Reis (ORCID: https://orcid.org/0000-0002-6750-0187)
- Vanessa Azevedo (ORCID: https://orcid.org/0000-0003-4850-258X)
- Michael Marks (ORCID: https://orcid.org/0000-0002-7585-4743)
- Linda Campbell (ORCID: https://orcid.org/0000-0002-8872-9626)
- Joel M Francis (ORCID: https://orcid.org/0000-0003-1902-2683)
- Amr Abdelhamed (ORCID: https://orcid.org/0000-0002-1700-2964)
- Simukai Shamu (ORCID: https://orcid.org/0000-0002-2290-0515)
- Stefano Eleuteri (ORCID: https://orcid.org/0000-0002-8416-2845)
- Joseph D. Tucker (ORCID: https://orcid.org/0000-0003-2804-1181)
- Adenike Abisola Osiberu
- Satenik Sahakyan (ORCID: https://orcid.org/0009-0006-2023-5263)
Institutions
- University of North Carolina at Chapel Hill (US)
- Universidade Federal da Bahia (BR)
- University College Hospital (GB)
- University of Antwerp (BE)
- Fernando Pessoa University (PT)
- National University of Singapore (SG)
- University of Ibadan (NG)
- Universidade do Porto (PT)
- University of Luxembourg (LU)
- University of the Witwatersrand (ZA)
- University College Hospital, Ibadan (NG)
- Royal London Hospital (GB)
- Taoka Hospital (JP)
- London School of Hygiene & Tropical Medicine (GB)
- Hospital for Tropical Diseases (GB)
- Mikaelyan Institute of Surgery (AM)
- National University Health System (SG)
- Training Programs in Epidemiology and Public Health Interventions Network (US)
- University College London (GB)
- Sapienza University of Rome (IT)
- Sohag University (EG)
Publication Details
- Journal
- Journal of Aggression Maltreatment & Trauma
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1080/10926771.2024.2431731
- Citations
- 2
- Primary Topic
- Intimate Partner and Family Violence
- Type
- article
- Field-Weighted Citation Impact
- 1.06
Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases